Filter By Category

Insights

Why We Need Innovative Nuclear Energy

Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.

Read More

Insights

Why We’re Reinventing the Door and Window

A new study by Global Good and its partners explores how reinventing two common household items—the window and door—could save lives by keeping pesky mosquitoes out of African homes.

Read More

Insights

Founder and CEO Nathan Myhrvold Upends Asteroid Assumptions in New Study

In a new study published in the journal Icarus, Nathan argues that astronomers don’t have as good a handle on the size and other physical characteristics of asteroids as they previously thought.

Read More

Insights

Intellectual Ventures Develops the First Offline Virtual Malaria Microscopy Training Course

The World Health Organization-approved eLearning tool can be used regardless of Internet access.

Read More

Press Releases

JP Selecta, Global Good Collaboration Brings Novel Microbiology Incubator to Market

Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.

Read More

Press Releases

UC San Diego and Invention Science Fund Collaborate to Create New Technology Startups

$1 million invested in Institute for the Global Entrepreneur at UC San Diego. 

Read More

Press Releases

Dominion Harbor Deepens its Relationship with Intellectual Ventures

Dominion Harbor and IV to work together to provide greater access to IV portfolio.

Read More

Press Releases

Intellectual Ventures and Huawei Enter License Agreement

As a result of the agreement with IV, Huawei has license to patents related to mobile devices.

Read More

Publications

New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia.

With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.

Read More

Publications

Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru.

Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.

Read More

Publications

Polydisperse emulsion digital assay to enhance time to detection and extend dynamic range in bacterial cultures enabled by a statistical framework.

Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.

Read More

Publications

Improving Lateral Flow Assay Performance Using Computational Modeling.

Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.

Read More

Media Coverage

Bellevue research scientist is on a mission to improve global health equality

The Seattle Times

IV research scientist Corrie Ortega shares her background and what her experience at IV has been like in this Seattle Times Q&A.

Read More

Media Coverage

From Corporate To Startups: How This Entrepreneur Did It And Landed Bill Gates As An Investor

Forbes

CEO of IV spinout Evolv recently joined the DealMakers Podcast to discuss his background and provide some insights for aspiring entrepreneurs. 

Read More

Media Coverage

Bill Gates’ new crusade: Sounding the climate-change alarm

Axios

IV spinout TerraPower continues to develop innovative nuclear energy technology, making it safer, more efficient, and cheaper.

Read More

Media Coverage

Picture perfect: Nathan Myhrvold’s eye-popping pictures of food

CBS Sunday Morning

Our founder and CEO Nathan Myhrvold shares his experience with high speed food photography and other culinary pursuits with David Pogue.

Read More

Popular Tags

inventors invention global good nathan myhrvold stem iv lab secondary market patent reform licensing historical adriane brown u.s. economy invention science fund global health litigation commercialization edward jung patent policy portfolio partner idf c-suite customer asia